Ragbourne, Sophie C. and Crook, Martin A. (2015) Use of lipid-lowering medications in myasthenia gravis: A case report and literature review. Journal of Clinical Lipidology, 9 (2). pp. 256-259. ISSN 1933-2874 (doi:10.1016/j.jacl.2014.12.005)

Full text not available from this repository.

Abstract

We present a patient with myasthenia gravis (MG) who developed worsening of his condition after starting ezetimibe. We review the literature concerning lipid-modifying medications and MG.

The use of bile acid sequestrant agents may have a place in the lipid management of MG patients because they did not seem to cause muscle-related side effects or worsening of MG.

Item Type:	Article
Uncontrolled Keywords:	Ezetimibe, Hyperlipidemia, Myasthenia gravis, myopathy, statins
Subjects:	R Medicine > RS Pharmacy and materia medica
Faculty / School / Research Centre / Research Group:	Faculty of Engineering & Science Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Related URLs:	Publisher
Last Modified:	09 Oct 2021 04:45
URI:	http://gala.gre.ac.uk/id/eprint/13165

Actions (login required)

View Item